IGM Financial Inc. (TSE:IGM – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six research ...

Steven Weber, the Principal Accounting Officer at IGM Biosciences, Inc. (NASDAQ:IGMS), recently sold shares of the company's common stock. The transaction comes as the stock has experienced ...

On Friday, IGM Biosciences Inc (IGMS) stock saw a decline, ending the day at $2.09 which represents a decrease of $-4.11 or -66.29% from the prior close of $6.2. The stock opened at $2.01 and touched ...

Bank of America Securities analyst Charlie CY Yang maintained a Hold rating on IGM Biosciences (IGMS – Research Report) today. The company’s ...

Wedbush restated their neutral rating on shares of IGM Biosciences (NASDAQ:IGMS – Free Report) in a report issued on Friday ...

In other recent news, IGM Biosciences has experienced significant changes, including a strategic shift towards the autoimmune sector and a downsizing of its workforce by 73%. These changes have led to ...

The market's response to BMO Capital Markets' rating downgrade and the subsequent price target reduction reflects the uncertainty surrounding IGM Biosciences' path forward following the ...

IGM Biosciences has halted all oncology programs and faces a significant pipeline upheaval. Read why I maintain my Sell rating on IGMS stock.

The labor market ended 2024 on a strong note, adding 256,000 jobs in December, exceeding economist forecasts and showcasing once again the resilience of the U.S. economy. Nonfarm payrolls rose by 256, ...